Patrick Akande
Overview
Explore the profile of Patrick Akande including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
51
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oladele R, Jordan A, Akande P, Akanmu S, Akase I, Aliyu S, et al.
PLoS One
. 2020 Jul;
15(7):e0235577.
PMID: 32628714
Background: Nigeria is estimated to have 25,000 cases of cryptococcal antigenemia (CrAg) annually. CrAg screening with pre-emptive fluconazole treatment is recommended but not yet implemented in Nigeria. Trainings were conducted...
2.
Ibiloye O, Akande P, Plang J, Emerenini F, Omole T, Osindero O, et al.
Int Health
. 2020 Jun;
13(2):196-198.
PMID: 32478384
Background: Stigma affects access and treatment outcomes in men who have sex with men. We assessed the effect of novel community health worker-led antiretroviral therapy delivery (CLAD). Methods: A retrospective...
3.
Akanbi M, Achenbach C, Taiwo B, Idoko J, Ani A, Isa Y, et al.
BMC Pulm Med
. 2017 Jun;
17(1):87.
PMID: 28558662
Background: Xpert MTB/Rif (Xpert) is described as a game changer in tuberculosis (TB) control. We evaluated the impact of Xpert on diagnosis, time to treatment, and treatment outcome among patients...
4.
Chang C, Meloni S, Eisen G, Chaplin B, Akande P, Okonkwo P, et al.
Open Forum Infect Dis
. 2015 Nov;
2(4):ofv154.
PMID: 26613097
Background. Despite the benefits of antiretroviral therapy (ART), tuberculosis (TB) is the leading cause of mortality among human immunodeficiency virus (HIV)-infected persons in Africa. Nigeria bears the highest TB burden...
5.
Dinic L, Idigbe O, Meloni S, Rawizza H, Akande P, Eisen G, et al.
J Acquir Immune Defic Syndr
. 2013 Feb;
63(2):168-77.
PMID: 23392466
Background: Tuberculosis (TB) diagnosis in most resource-limited settings still depends on smear microscopy for identification of acid-fast bacilli (AFB). However, recently developed molecular diagnostics that test for the presence of...
6.
Dinic L, Akande P, Idigbe E, Ani A, Onwujekwe D, Agbaji O, et al.
J Clin Microbiol
. 2012 Jun;
50(9):2905-9.
PMID: 22740709
Tuberculosis (TB) is the most common opportunistic infection in human immunodeficiency virus (HIV)-infected patients and the emergence of drug-resistant tuberculosis (DR-TB) is a growing problem in resource-limited settings. Adequate infrastructure...